3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-5-((2-(trifluoromethoxy)benzyl)oxy)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione

Catalog No. :
ACNACA445
CAS No. :
-
Molecular Formula :
C26H20F4IN3O5
Molecular Weight :
657.36

IUPAC Name:3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-5-((2-(trifluoromethoxy)benzyl)oxy)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione

3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-5-((2-(trifluoromethoxy)benzyl)oxy)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00Login to see priceInquiryInquiry
250mg95%$715.00Login to see priceInquiryInquiry
1g95%$1540.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-5-((2-(trifluoromethoxy)benzyl)oxy)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione
IUPAC Name3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-5-((2-(trifluoromethoxy)benzyl)oxy)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione
Molecular FormulaC26H20F4IN3O5
Molecular Weight657.36
SMILESCC1=C(OCC2=CC=CC=C2OC(F)(F)F)C2=C(N(C)C1=O)N(C1=CC=C(I)C=C1F)C(=O)N(C1CC1)C2=O
InChI KeyUSAZJBHLJOSSMU-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACNACA445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPWZL680 route compound structure diagram
    ACPWZL680871700-24-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNACA445 route product structure diagram
    ACNACA445-
Inquiry

2. ACNACA445 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPWZL680 route compound structure diagram
    ACPWZL680871700-24-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNACA445 route product structure diagram
    ACNACA445-
Inquiry

Comments (0)